Related Experiment Video
Updated: Jun 16, 2026

A High-Throughput In Situ Method for Estimation of Hepatocyte Nuclear Ploidy in Mice
Published on: April 19, 2020
Genome near-haploidization in CDC73-wildtype parathyroid tumors
Maaia Margo Jentus1, Filomena Cetani2, Marieke Snel3
1Department of Pathology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333, ZA, The Netherlands. m.jentus@lumc.nl.
Abstract:
Parathyroid carcinoma (PC) is most often linked to germline or somatic CDC73 mutations. Previously, we identified three CDC73-wildtype PCs with massive chromosomal losses and genome near-haploidization, with or without endoreduplication/genome doubling - features also seen in rare tumor types such as oncocytic thyroid carcinoma. To assess whether similar alterations occur in other parathyroid neoplasms, we analyzed fourteen parathyroid adenomas (PA; thirteen oncocytic), three atypical parathyroid tumors (APTs; one oncocytic), and one additional PC, the latter four all CDC73-wildtype. Histopathological diagnoses followed the 2022 WHO classification. Genome-wide SNP array analysis was performed to detect copy number variations (CNVs), imbalances and loss of heterozygosity (LOH). APTs and PC underwent somatic mutation analysis, to confirm CDC73-wildtype status. Oncocytic PAs exhibited largely stable genomes, with few or no chromosomal alterations. Patients with chromosomally altered PA had significantly higher preoperative serum calcium levels. In contrast, two of three APTs, and the included PC displayed extensive chromosomal losses and genome near-haploidization. These findings expand the recognized spectrum of chromosomal alterations in CDC73-wildtype parathyroid tumors.
Insights
Chromosomal alterations, including genome near-haploidization, are found in some CDC73-wildtype parathyroid tumors, particularly atypical parathyroid tumors and parathyroid carcinoma. Oncocytic parathyroid adenomas generally show stable genomes.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Parathyroid carcinoma (PC) is typically associated with CDC73 mutations.
- Rare CDC73-wildtype PCs exhibit massive chromosomal losses and genome near-haploidization.
- These genomic features are also observed in other rare tumors, like oncocytic thyroid carcinoma.
Purpose of the Study:
- To investigate chromosomal alterations in CDC73-wildtype parathyroid adenomas (PAs), atypical parathyroid tumors (APTs), and PC.
- To determine if genome near-haploidization occurs in these parathyroid neoplasms.
Main Methods:
- Histopathological diagnosis using the 2022 WHO classification.
- Genome-wide SNP array analysis for copy number variations (CNVs), imbalances, and loss of heterozygosity (LOH).
- Somatic mutation analysis for CDC73-wildtype confirmation in APTs and PC.
Main Results:
- Oncocytic PAs generally had stable genomes with minimal chromosomal alterations.
- Two of three APTs and the analyzed PC showed extensive chromosomal losses and genome near-haploidization.
- Patients with chromosomally altered PAs had significantly higher preoperative serum calcium levels.
Conclusions:
- Extensive chromosomal losses and genome near-haploidization are features of some CDC73-wildtype atypical parathyroid tumors and parathyroid carcinoma.
- These findings broaden the understanding of genomic alterations in parathyroid tumors lacking CDC73 mutations.
Related Concept Videos
Abnormal Proliferation
Histone Variants at the Centromere
The Nucleolus
